课题基金 / 基金详情

RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES

RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
网状细胞结合样 (RBL) 蛋白作为新一代疟疾疫苗
批准号:
8172457
负责人:
MARY R GALINSKI
金额:
$5.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30

项目摘要

项目成果

MARY R GALINSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this project is to test the efficacy of P. knowlesi Normocyte Binding Protein red blood cell adhesive domain as a vaccine in rhesus monkeys. This is a new, recently awarded project. Progress to date includes the development of constructs for producing the immunogen that will be tested in rhesus monkeys.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Approach to Host-Pathogen Interactions
  • 批准号:
    8564414
  • 项目类别:
  • 资助金额:
    $338.93万
  • 财政年份:
    2012
  • 负责人:
    MARY R GALINSKI
  • 依托单位:
Plasmodium cynomolgi as a model for P. vivax.
  • 批准号:
    8290557
  • 项目类别:
  • 资助金额:
    $17.6万
  • 财政年份:
    2011
  • 负责人:
    MARY R GALINSKI
  • 依托单位:
RBL Binding Domain Malaria Candidate Vaccines
  • 批准号:
    8104854
  • 项目类别:
  • 资助金额:
    $30.8万
  • 财政年份:
    2011
  • 负责人:
    MARY R GALINSKI
  • 依托单位:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
  • 批准号:
    8357495
  • 项目类别:
  • 资助金额:
    $4.12万
  • 财政年份:
    2011
  • 负责人:
    MARY R GALINSKI
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究